Shenzhen Hepalink (海瑞普) A+H: Hot Deal that Might Not Fly
506 Views23 Jun 2020 05:06
Shenzhen Hepalink, a leading heparin manufacturer in China, launched book building to raise up to USD 585 million to list in Hong Kong.
In our...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »Loading
Trending Collections
More »Loading
Trending Insights
More »Loading
Top Unpaywalled Insights
More »Loading
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Shenzhen Hepalink (海普瑞) A+H Trading: 20% Upside Thanks to A-Share Performance07 Jul 2020
- Shenzhen Hepalink (海瑞普) A+H: Hot Deal that Might Not Fly23 Jun 2020
- Shenzhen Hepalink (海瑞普) A+H: FY2019 Results Snippet and Valuation Update17 Apr 2020
- Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting19 Feb 2020
x